Development of adenoviral-vector-based pandemic influenza vaccine against antigenically distinct human H5N1 strains in mice
Mary Hoelscher(Centers for Disease Control and Prevention), Suryaprakash Sambhara(Centers for Disease Control and Prevention), Suresh K. Mittal(Purdue University West Lafayette), Sanjay Garg(The University of Adelaide), Jessica A. Belser(Centers for Disease Control and Prevention), Rick A. Bright(Waterford Institute), Dinesh S. Bangari(Sanofi (United States)), Jacqueline M. Katz(National Center for Immunization and Respiratory Diseases), Xiuhua Lu(Centers for Disease Control and Prevention), Iain Stephenson(Centers for Disease Control and Prevention)
Cited by 188
Related Papers
Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults
|New England Journal of Medicine|2015|3.4k
Community-Acquired Pneumonia Requiring Hospitalization among U.S. Children
|New England Journal of Medicine|2015|1.9k
Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern
|The Lancet|2005|734
Adamantane Resistance Among Influenza A Viruses Isolated Early During the 2005-2006 Influenza Season in the United States
|JAMA|2006|672
Transmission of Equine Influenza Virus to Dogs
|Science|2005|652